ArticleActa crystallographica. Section D, Structural biology2019

Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1.

Jakub Luptak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.